Dual inhibition - new trend in the treatment of dyslipidemias

Abstract

Ezetimibe is a new drug, which blocks the cholesterol absorption from the small bowel. Statins inhibit the cholesterol synthesis in cells.

The both effects completelly and easily reduce plasma cholesterol level.

Keywords

• inhibition
• trend
• treatment
• dyslipidemias